The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -19,951 |
| Depreciation and amortization | 2,118 |
| Amortization of debt discount and debt issuance costs | 378 |
| Amortization of loan commitment fees | 738 |
| Change in fair value of warrant liability | 1,506 |
| Loss on extinguishment of debt | -295 |
| Non-cash operating lease expense | 967 |
| Stock-based compensation | 2,158 |
| Other | -147 |
| Accounts receivable, net | 3,020 |
| Prepaid expenses and other current assets | -1,108 |
| Other assets | -792 |
| Operating lease liabilities | -1,096 |
| Accounts payable | 42 |
| Deferred revenue | -58 |
| Accrued and other current liabilities | 251 |
| Net cash used in operating activities | -13,625 |
| Purchases of property and equipment | 641 |
| Proceeds from disposal of property and equipment | 15 |
| Net cash used in investing activities | -626 |
| Proceeds from common stock issued in public offering, net of issuance costs | 18,627 |
| Proceeds from common stock issued under atm, net of issuance costs | 3,398 |
| Proceeds from common stock issued under employee stock purchase plan | 398 |
| Proceeds from exercise of stock options | 0 |
| Principal payment on finance lease obligations | 494 |
| Principal payment on note payable obligations | 592 |
| Proceeds from issuance of debt and warrants, net of discounts | 23,672 |
| Payment to extinguish debt | 19,705 |
| Payment of debt issuance costs | 869 |
| Net cash provided by (used in) financing activities | 24,435 |
| Net change in cash, cash equivalents and restricted cash | 10,184 |
| Cash, cash equivalents and restricted cash, beginning of year | 22,236 |
| Cash, cash equivalents and restricted cash, end of year | 32,420 |
EXAGEN INC. (XGN)
EXAGEN INC. (XGN)